RT Book, Section
A1 Bottros, Michael M.
A1 Erdek, Michael A.
A2 Diwan, Sudhir
A2 Staats, Peter S.
SR Print(0)
ID 1107200890
T1 Chemical Neurolysis
T2 Atlas of Pain Medicine Procedures
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071738767
LK accessanesthesiology.mhmedical.com/content.aspx?aid=1107200890
RD 2024/04/18
AB Neurolytic  techniques  have  long  been  used  in  the  treatment  of  pain.  The  underlying  principle  for  neurolytic  blocks  is  prolonged  relief  of  intractable  pain,  most  often  in  patients  with  malignancies.  Pain  associated  with  cancer  may  be  visceral,  somatic,  and/or  neuropathic  in  origin.  Many  cancer  patients  have  a  combination  of  these  pain  types  at  the  time  of  their  diagnosis.  Pain  is  often  reported  when  visceral  structures  are  compressed,  invaded,  or  distended.  Visceral  pain  is  often  described  as  vague,  dull,  deep,  constricting,  crampy,  or  colicky  in  nature.  Empirical  data  suggests  that  visceral  sympathetically-mediated  pain  responds  more  favorably  to  neurolytic  therapy  than  neuropathic  pain.1